共 50 条
- [5] Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-naive patients with type 2 diabetes: a randomized, double-blind, 6-month study [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (07): : 613 - 621
- [8] Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study) [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (01): : 87 - 97